Effect of 2-year cladribine treatment on brain volume in highly active relapsing MS patients

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2023
This article has no abstract
Epistemonikos ID: 66f90c33b7cc512f6eeaf66c46a801f58ecb1c07
First added on: Apr 30, 2026